In Veritas Medical Stock Performance
| IVME Stock | USD 0.0001 0.00 0.00% |
The company owns a Beta (Systematic Risk) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and In Veritas are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days In Veritas Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, In Veritas is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Last Split Factor 9.009:1 | Last Split Date 2004-06-23 |
| Total Cashflows From Investing Activities | -69 K |
IVME |
In Veritas Relative Risk vs. Return Landscape
If you would invest 0.01 in In Veritas Medical on September 19, 2024 and sell it today you would earn a total of 0.00 from holding In Veritas Medical or generate 0.0% return on investment over 90 days. In Veritas Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than IVME, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
In Veritas Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for In Veritas' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as In Veritas Medical, and traders can use it to determine the average amount a In Veritas' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| IVME |
Based on monthly moving average In Veritas is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of In Veritas by adding In Veritas to a well-diversified portfolio.
In Veritas Fundamentals Growth
IVME Stock prices reflect investors' perceptions of the future prospects and financial health of In Veritas, and In Veritas fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IVME Stock performance.
| Return On Asset | -6.48 | ||||
| Current Valuation | 8.6 K | ||||
| Shares Outstanding | 86.05 M | ||||
| Price To Earning | (0.01) X | ||||
| Price To Sales | 0.14 X | ||||
| EBITDA | (2.07 M) | ||||
| Net Income | (3.67 M) | ||||
| Total Debt | 1.21 M | ||||
| Book Value Per Share | (0.13) X | ||||
| Cash Flow From Operations | (727.72 K) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 8.61 K | ||||
| Total Asset | 111.95 K | ||||
About In Veritas Performance
By analyzing In Veritas' fundamental ratios, stakeholders can gain valuable insights into In Veritas' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if In Veritas has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if In Veritas has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (257.37) | (244.50) | |
| Return On Capital Employed | (0.39) | (0.40) | |
| Return On Assets | (37.71) | (35.82) | |
| Return On Equity | 0.47 | 0.30 |
Things to note about In Veritas Medical performance evaluation
Checking the ongoing alerts about In Veritas for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for In Veritas Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| In Veritas Medical generated a negative expected return over the last 90 days | |
| In Veritas Medical has some characteristics of a very speculative penny stock | |
| In Veritas Medical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (3.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| In Veritas generates negative cash flow from operations | |
| In Veritas Medical has a frail financial position based on the latest SEC disclosures |
- Analyzing In Veritas' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether In Veritas' stock is overvalued or undervalued compared to its peers.
- Examining In Veritas' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating In Veritas' management team can have a significant impact on its success or failure. Reviewing the track record and experience of In Veritas' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of In Veritas' stock. These opinions can provide insight into In Veritas' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for IVME Stock analysis
When running In Veritas' price analysis, check to measure In Veritas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In Veritas is operating at the current time. Most of In Veritas' value examination focuses on studying past and present price action to predict the probability of In Veritas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In Veritas' price. Additionally, you may evaluate how the addition of In Veritas to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |